Lv1
10 积分 2025-07-30 加入
Hitting the Mark — Individualizing Therapy for HER2-Positive Early-Stage Breast Cancer
2个月前
已完结
Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors
9个月前
已完结
The generative era of medical AI
9个月前
已完结
The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
10个月前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
10个月前
已完结
皖公网安备34019202002308
